Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07293286

Effect of Different Oxygen Concentrations Before Extubation After General Anesthesia on Hypoxemia After Extubation in Post-anesthesia Care Unit

Effect of Different Oxygen Concentrations During the Recovery Period Before Extubation After General Anesthesia on Hypoxemia After Extubation in Post-anesthesia Care Unit

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
590 (estimated)
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Before extubation during the anesthesia recovery period, 100% oxygen is routinely inhaled to increase the oxygen reserves, maximizing the time window for anesthesiologists to adjust strategies when they encounter hypoxemia after extubation. However, even inhaling a short period of pure oxygen can cause absorptive atelectasis, and may even impair the effectiveness of intraoperative protective ventilation measures continuing to post-operative period. The purpose of this study is to determine whether 30% oxygen before extubation after abdominal surgery could reduce hypoxemia incidence after extubation during the recovery period or not, compared to 100% oxygen. 590 patients scheduled to abdominal surgeries, will be randomly assigned to receive 30% or 100% oxygen concentration from the end of surgery to extubation after general anesthesia in the post-anesthesia care unit. The incidence of hypoxemia (SpO2 \< 90%) from extubation to leaving the post-anesthesia care unit (PACU) is the primary outcome.

Conditions

Interventions

TypeNameDescription
OTHER100% oxygen concentration inhaledOxygen concentration inhaled from the end of surgery to tracheal extubation after general anesthesia in the recovery period is 100%.
OTHER30% oxygen concentration inhaledOxygen concentration inhaled from the end of surgery to tracheal extubation after general anesthesia in the recovery period is 30%.

Timeline

Start date
2025-12-30
Primary completion
2026-05-30
Completion
2026-06-30
First posted
2025-12-19
Last updated
2025-12-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07293286. Inclusion in this directory is not an endorsement.